drugset / Trial / NCT01127555
Salvage mFOLFOX in BTC After Failure of Gemcitabine
Phase 2
Completed
30 enrolled
Chung-Ang University
Dong-A University Hospital · collabGyeongsang National University Hospital · collabSamsung Medical Center · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of mFOLFOX (5-fluorouracil, leucovorin, oxaliplatin)as salvage therapy in patients with unresectable biliary tract cancer who had failed gemcitabine.
Timeline
- Start
- 2010-04
- Primary completion
- 2012-06
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leucovorin | Small molecule | 30 mg/m2 | Intravenous |
| Subject | Oxaliplatin | Small molecule | 85 mg/m2 | — |
| Subject | fluorouracil | Small molecule | 1500 mg/m2 | Intravenous |